Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer

Area of Science:

• Endocrinology
• Surgical Oncology
• Thyroid Cancer Research

Background:

• Medullary thyroid carcinoma (MTC) is the third most common thyroid malignancy.
• Early metastasis to local lymph nodes is characteristic of MTC.
• Total thyroidectomy with central lymph node dissection (CLND) is often recommended for initial MTC management.

Purpose of the Study:

• To evaluate the impact of initial surgical procedures on clinical outcomes in medullary thyroid carcinoma.
• To compare the effectiveness of thyroidectomy with and without CLND for MTC.

Main Methods:

• Retrospective review of 22 patients with MTC undergoing surgery between 1994 and 2004.
• Analysis of clinical, operative, and pathology findings.
• Comparison of outcomes between prophylactic (hereditary MTC) and therapeutic (sporadic MTC) surgical groups, with subgroup analysis of CLND inclusion.

Main Results:

• No residual disease or re-operations were observed in the prophylactic thyroidectomy group (n=10).
• In the therapeutic group (n=12), patients undergoing thyroidectomy plus CLND (n=3) had a significantly lower incidence of residual disease (0% vs. 89%, p=0.018) and re-operations (0% vs. 78%, p=0.045) compared to those with thyroidectomy alone (n=9).

Conclusions:

• Initial central lymph node dissection (CLND) for medullary thyroid carcinoma (MTC) is associated with improved cure rates.
• Performing CLND as part of the initial operation for MTC reduces the likelihood of residual disease and the need for subsequent re-operations.